Top Medical News

Dostarlimab Elicits Superior Responses in Patients with High Mutational Burden in Endometrial Cancer

September 17th 2021

Patients with endometrial cancer and high tumor mutational burden experienced superior overall response rates to the agent dostarlimab than patients with low mutational burden.

COVID-19 Pandemic Emphasizes Disparities in Cancer Care

September 17th 2021

“We’ve had periods of time where things were shut down. We do have telemedicine, that was expanded, but telemedicine doesn’t work for everyone. If you don’t have internet access, if you don’t have the ability to understand the technology….”

Addition of Darolutamide to ADT Shows Comparable Safety Profile Among Patients With nmCRPC

September 16th 2021

Patients with nonmetastatic castration-resistant prostate cancer often undergo prolonged treatment periods, making the safety profile of therapies like darolutamide an important factor in optimum treatment selection.

Yoga Encourages Antitumor Response, Boosts Quality of Life in Patients with Prostate Cancer

September 16th 2021

Yoga has a positive impact on the vagus nerve, which influences how people think, remember, and feel, and therefore can improve the mental well-being of patients with prostate cancer.

FDA Approves Mobocertinib for NSCLC with EGFR Exon 20 Insertion Mutations

September 15th 2021

The FDA has green lit mobocertinib for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with an EGFR exon 20 insertion mutation.

Most Recent